Ekaterina A. Goncharova

Papers

Total Citations

H-Index

About

Ekaterina A. Goncharova is a leading researcher at the intersection of nucleic acid chemistry and nanotechnology, with her work centered on the development of intelligent, RNA-targeting therapeutic and diagnostic platforms. Her major contributions lie in engineering bifunctional deoxyribozyme (DNAzyme) nanodevices that act as theranostic agents—capable of simultaneously detecting a specific RNA biomarker through a fluorescence signal and cleaving that same target for therapeutic effect. This dual-action approach, detailed in her highly cited 2020 paper, demonstrates remarkable selectivity under near-physiological conditions, offering a powerful strategy for diseases where aberrant RNA expression is key. With over 14 citations on this flagship work alone, her research has quickly gained recognition for its potential to transform personalized medicine by combining real-time diagnostics with targeted gene silencing. Goncharova’s innovative design of these DNA-based nanomachines represents a significant leap forward in the field of RNA-targeted theranostics, establishing her as a rising authority in smart drug delivery and molecular imaging.